Skip to content

Effect of an Integrated Nursing Intervention Based on Swanson's Theory of Caring on Health Outcomes in Patients with AECOPD and Frailty: A Randomized Controlled Study

Effect of an Integrated Nursing Intervention Based on Swanson's Theory of Caring on Health Outcomes in Patients with AECOPD and Frailty: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125970
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute exacerbation of chronic obstructive pulmonary disease

Interventions

Control Group (Routine Care Group):Routine Care for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Frailty
Experimental Group (Integrated Nursing Group Based on Swanson's Theory of Caring):Integrated Nursing Program Based on Swanson's Theory of Caring

Sponsors

Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 60 years; 2. Meet the diagnostic criteria for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) specified in the Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease, and hospitalized due to AECOPD; 3. Score >= 4 (mild frailty or above) on the Clinical Frailty Scale (CFS); 4. Clear consciousness, normal verbal communication ability, and ability to cooperate with scale assessments and study interventions; 5. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cognitive impairment (e.g., Alzheimer's disease) or psychiatric disorders (e.g., schizophrenia, bipolar disorder); 2. Patients with end-stage diseases (e.g., advanced tumors, end-stage renal disease, liver failure) or with an expected survival time of less than 6 months based on clinical assessment; 3. Patients who are participating in other ongoing interventional clinical trials within 3 months prior to the start of this study; 4. Patients with limb dysfunction or severe visual/hearing impairment that prevents them from completing scale assessments; 5. Patients without a fixed contact address/phone number who are expected to be unable to complete the required follow-up.

Design outcomes

Primary

MeasureTime frame
Score difference of the COPD Assessment Test (CAT);

Secondary

MeasureTime frame
90-day unplanned readmission rate;Score difference of the Chronic Disease Self-Efficacy Scale;Changes in Clinical Frailty Scale (CFS) grades;Score difference of the Morisky Medication Adherence Scale;Incidence of adverse events;

Countries

China

Contacts

Public ContactGu Jinxin

Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

283177028@qq.com+86 660 386 3831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026